The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-B/NLRP3 inflammasome signaling pathway

Yi-hao Wang,Yu-ru Tang,Xiao Gao,Juan Liu,Nan-nan Zhang,Zhao-jun Liang,Yan Li,Li-xiao Pan
DOI: https://doi.org/10.1016/j.brainresbull.2021.01.015
IF: 3.715
2021-01-01
Brain Research Bulletin
Abstract:Objective: To explore the potential analgesic effect of melatonin and its underlying molecular mechanisms in a neuropathic pain model induced by spinal nerve ligation (SNL). Methods: The experimental animals were divided into different groups including sham, vehicle, melatonin (MT) treatment, caspase-1 inhibitor (VX-765) treatment and MT2 antagonist (4P-PDOT) treatment. On the first three successive postoperative days, rats were intraperitoneally administered with MT, VX-765 or combination of MT and 4P-PDOT. Hyperalgesic behavior after SNL was evaluated using the paw withdrawal threshold (PWT). We then assessed expression of tumor necrosis factor-alpha (TNF-alpha), IL-18, interleukin-1 beta (IL-1 beta) NLRP3 inflammasome components, and nuclear factor-kappa B (NF-kappa B) activation using enzyme-linked immunosorbent assay kits (ELISA), real-time PCR, immunohistochemistry, and western blot, respectively, in spinal cord horn tissues extracted on postoperative day 7. Results: The results showed that melatonin treatment alleviated SNL-induced allodynia. We observed an SNL- induced upregulation of TNF-alpha, IL-18, IL-1 beta, NLRP3, ASC, cleaved caspase-1, and NF-kappa B in the lumbar spinal cord horn of rats, which was significantly attenuated by intraperitoneal injection of melatonin or VX-765. Additionally, co-treatment of melatonin and 4P-PDOT abrogated the analgesic and anti-inflammatory effect of melatonin. Conclusion: Melatonin had potent analgesic and anti-inflammatory effects in SNL-induced neuropathic pain via NF-kappa B/NLRP3 inflammasome signaling pathway. Our results therefore suggested that this pathway could represent a novel therapeutic target for the management of neuropathic pain.
What problem does this paper attempt to address?